Aurobindo Pharma Hits 52-Week High, Gains for Fifth Consecutive Session
Aurobindo Pharma has reached a 52-week high of around Rs 1700, gaining approximately 7-9% in the past month and rising for five consecutive sessions. This performance contrasts with broader market declines, including a 0.4% drop in the Sensex and a 2.24% slide in the NIFTY over the past year. Other stocks like Lenskart Solutions and Coforge also hit 52-week highs amid mixed market sentiment, indicating selective investor interest in certain sectors despite overall weakness.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (60/100). Lens Score 31/100.
Outlets measured: economictimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (55–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 31 Aug, 08:37 am. Other outlets followed.